ArticleJournal of clinical medicine2021
Impact of Idarucizumab and Andexanet Alfa on DOAC Plasma Concentration and ClotPro
Daniel Oberladstätter et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this paperpooled itcites it